Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Current Assets: 2020-2023

Historic Current Assets for Cullinan Therapeutics (CGEM) over the last 3 years, with Sep 2023 value amounting to $476.7 million.

  • Cullinan Therapeutics' Current Assets fell 18.10% to $476.7 million in Q3 2023 from the same period last year, while for Sep 2023 it was $476.7 million, marking a year-over-year decrease of 18.10%. This contributed to the annual value of $474.5 million for FY2022, which is 59.99% up from last year.
  • According to the latest figures from Q3 2023, Cullinan Therapeutics' Current Assets is $476.7 million, which was down 4.32% from $498.2 million recorded in Q2 2023.
  • Cullinan Therapeutics' 5-year Current Assets high stood at $622.8 million for Q2 2022, and its period low was $212.3 million during Q4 2020.
  • Over the past 3 years, Cullinan Therapeutics' median Current Assets value was $447.3 million (recorded in 2021), while the average stood at $435.7 million.
  • Examining YoY changes over the last 5 years, Cullinan Therapeutics' Current Assets showed a top increase of 80.81% in 2022 and a maximum decrease of 27.94% in 2022.
  • Cullinan Therapeutics' Current Assets (Quarterly) stood at $212.3 million in 2020, then skyrocketed by 39.71% to $296.6 million in 2021, then skyrocketed by 59.99% to $474.5 million in 2022, then dropped by 18.10% to $476.7 million in 2023.
  • Its Current Assets stands at $476.7 million for Q3 2023, versus $498.2 million for Q2 2023 and $399.0 million for Q1 2023.